Full Press Release Details
kevzara sarilumab approved by fda for the treatment of active polyarticular juvenile idiopathic arthritis pjia.
REGN
kevzara sarilumab approved by fda for the treatment of active polyarticular juvenile idiopathic arthritis pjia
Key Takeaway: kevzara sarilumab approved by fda for the treatment of active polyarticular juvenile idiopathic arthritis pjia